ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc. is a biotechnology company based in Rancho Cordova, California, founded in 1986. The company specializes in developing and marketing automated technologies and medical devices for cell banking, cell processing, and cell-based therapeutics. It operates internationally, with a presence in the United States, China, the United Arab Emirates, and Vietnam. The company offers a variety of products aimed at automated cell processing and clinical biobanking. Notable products include the AXP II Automated Cell Separation System, which isolates stem and progenitor cells from umbilical cord blood, and the BioArchive Automated Cryopreservation System, designed for the freezing and storage of cord blood samples. The Res-Q System is another key device that processes stem cells from bone marrow. ThermoGenesis serves a diverse clientele, including cord blood banks, stem cell researchers, and clinical laboratories, supporting the harvesting and storage of stem cells and blood components. ThermoGenesis operates an FDA-registered manufacturing facility and adheres to current Good Manufacturing Practices (cGMP). The company is committed to quality and provides various support services, including Quality Management and Regulatory Affairs, to its clients.

• Employees 25
• Founded 1987
• Annual Revenue $9445000
• Total Funding $9446300